Financial Management Professionals Inc. Has $33,000 Position in Semler Scientific, Inc. (NASDAQ:SMLR)

Financial Management Professionals Inc. cut its position in shares of Semler Scientific, Inc. (NASDAQ:SMLR) by 55.2% during the 1st quarter, Holdings Channel reports. The firm owned 1,143 shares of the company’s stock after selling 1,410 shares during the quarter. Financial Management Professionals Inc.’s holdings in Semler Scientific were worth $33,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently modified their holdings of the company. Tower Research Capital LLC TRC increased its stake in shares of Semler Scientific by 250.5% during the 4th quarter. Tower Research Capital LLC TRC now owns 2,103 shares of the company’s stock worth $93,000 after purchasing an additional 1,503 shares during the last quarter. Advisory Services Network LLC acquired a new position in shares of Semler Scientific during the 4th quarter worth about $301,000. Nkcfo LLC acquired a new position in shares of Semler Scientific during the 4th quarter worth about $177,000. AJOVista LLC acquired a new position in shares of Semler Scientific during the 4th quarter worth about $58,000. Finally, LSV Asset Management increased its stake in shares of Semler Scientific by 10.7% during the 4th quarter. LSV Asset Management now owns 160,036 shares of the company’s stock worth $7,088,000 after purchasing an additional 15,490 shares during the last quarter. 49.37% of the stock is currently owned by institutional investors and hedge funds.

Semler Scientific Stock Performance

Shares of SMLR opened at $34.40 on Friday. Semler Scientific, Inc. has a 52 week low of $20.88 and a 52 week high of $53.38. The firm has a market cap of $243.21 million, a P/E ratio of 12.33 and a beta of 0.96. The firm’s 50-day simple moving average is $29.26 and its 200 day simple moving average is $36.22.

Semler Scientific (NASDAQ:SMLR) last posted its quarterly earnings data on Tuesday, May 7th. The company reported $0.78 earnings per share (EPS) for the quarter. The firm had revenue of $15.90 million during the quarter. Semler Scientific had a net margin of 32.92% and a return on equity of 30.36%.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. TheStreet upgraded shares of Semler Scientific from a “c+” rating to a “b-” rating in a research note on Friday, March 1st. Lake Street Capital upgraded shares of Semler Scientific to a “strong-buy” rating in a research note on Wednesday, May 8th.

Semler Scientific Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.